liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Survival outcomes and risk factors for liver and pancreatic metastases in renal cell carcinoma after curative nephrectomy
Linköping University, Department of Biomedical and Clinical Sciences, Division of Surgery, Orthopedics and Oncology. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Center for Surgery, Orthopaedics and Cancer Treatment, Department of Surgery in Linköping.
Skaraborg Hosp, Sweden.
Linköping University, Department of Biomedical and Clinical Sciences. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Center for Surgery, Orthopaedics and Cancer Treatment, Department of Urology in Östergötland.
Linköping University, Department of Health, Medicine and Caring Sciences. Linköping University, Faculty of Medicine and Health Sciences. Region Östergötland, Center for Diagnostics, Department of Radiology in Linköping.
Show others and affiliations
2025 (English)In: BMC Urology, E-ISSN 1471-2490, Vol. 25, no 1, article id 123Article in journal (Refereed) Published
Abstract [en]

BackgroundRenal cell carcinoma (RCC) has a high recurrence risk, with 20-40% of patients developing metastatic disease post-nephrectomy. This study aimed to identify risk factors associated with liver and pancreatic metastases in patients who have previously undergone curative nephrectomy for RCC.MethodsThis retrospective cohort study with a nested case-control design included adults who underwent nephrectomy for non-metastatic RCC (non-mRCC) between 2009 and 2021. Patients who developed liver or pancreatic metastases, confirmed by secondary surgery, formed the case group. A randomly selected control group of non-mRCC patients were included to assess risk factors. Clinical, radiological, and pathological data were analyzed.ResultsAmong 967 nephrectomy patients, 754 (78%) had RCC, and 6% developed liver or pancreatic metastases. Advanced tumor stage (T3) was a significant predictor of RCC metastasis in these patients. Patients with a prolonged disease-free interval demonstrated better surgical eligibility and survival outcomes. Median time from nephrectomy to metastasis was 57 months in surgical cases compared to 22 months in non-surgical cases. Notably, 92% of patients eligible for metastasis surgery had clear cell RCC (ccRCC). Surgical resection was associated with improved survival, with 1-, 3-, and 5-year survival rates of 92%, 83%, and 75%, respectively, compared to 77%, 65%, and 56% for non-surgical patients.ConclusionsAdvanced tumor stage and local invasiveness were key predictors of liver and pancreatic metastases in RCC. Prolonged time to metastasis improved surgical eligibility and survival. The majority of patients eligible for metastasis surgery had ccRCC. Further studies are needed to evaluate whether early, individualized follow-up for high-risk RCC subtypes improved surgical eligibility for liver and pancreatic metastasis.

Place, publisher, year, edition, pages
BMC , 2025. Vol. 25, no 1, article id 123
Keywords [en]
Liver and pancreatic metastasis; Metastasis; RCC; Renal cell carcinoma; Risk factors; Survival
National Category
Cancer and Oncology
Identifiers
URN: urn:nbn:se:liu:diva-213882DOI: 10.1186/s12894-025-01802-xISI: 001488121400001PubMedID: 40369561Scopus ID: 2-s2.0-105005230580OAI: oai:DiVA.org:liu-213882DiVA, id: diva2:1961557
Note

Funding Agencies|Linkping University

Available from: 2025-05-27 Created: 2025-05-27 Last updated: 2025-09-11

Open Access in DiVA

fulltext(1054 kB)46 downloads
File information
File name FULLTEXT01.pdfFile size 1054 kBChecksum SHA-512
3750666c075115d3e533642791587cdeecc605aa8a984a25e4746f94384b682a91449626047bad87641d2f0e728140d484d782910b29e1dcc0d064ef75bd61f4
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Hasselgren, KristinaShort, JenniferBendler, AnnaMehriban, YumerFredrikson, MatsHolmbom, Martin
By organisation
Division of Surgery, Orthopedics and OncologyFaculty of Medicine and Health SciencesDepartment of Surgery in LinköpingDepartment of Biomedical and Clinical SciencesDepartment of Urology in ÖstergötlandDepartment of Health, Medicine and Caring SciencesDepartment of Radiology in LinköpingClinical pathologyDivision of Inflammation and Infection
In the same journal
BMC Urology
Cancer and Oncology

Search outside of DiVA

GoogleGoogle Scholar
Total: 46 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 59 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf